Cigna-Express scripts deal gets anti-trust approval
September 17, 2018 at 15:04 PM EDT
Sept 17 - Health insurer Cigna Corp's $52 billion acquisition of pharmacy benefits manager Express Scripts Holding Co has passed U.S. antitrust scrutiny, the companies said on Monday, allowing a combination the companies say will lead to lower costs by better coordinating pharmacy and medical benefits.